FX LIFE SCIENCES INTERNAT GMBH has a total of 12 patent applications. Its first patent ever was published in 1998. It filed its patents most often in United States, EPO (European Patent Office) and Republic of Korea. Its main competitors in its focus markets pharmaceuticals, machines and biotechnology are FUMAPHARM AG, PROXIMAGEN GROUP LTD and DEPRENYL ANIMAL HEALTH INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | Republic of Korea | 2 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | Taiwan | 1 | |
#7 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Machines | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Unspecified technologies | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Shan Jacqueline J | 10 |
#2 | Pang Peter K T | 5 |
#3 | Ling Lei | 4 |
#4 | Huang Buhan | 3 |
#5 | Sutherland Sharla K | 3 |
#6 | Chiu Kam | 1 |
#7 | Totosy De Zepetnek Joanne | 1 |
#8 | Wu Xi-Chen | 1 |
#9 | Shan Jacqueline | 1 |
#10 | Guilbert Larry | 1 |
Publication | Filing date | Title |
---|---|---|
EP1940434A2 | Antioxidant and fe2+chelating properties of herbal extracts | |
US7195783B2 | Hypericin and hypericum extract: specific T-type calcium channel blocker, and their use as T-type calcium channel targeted therapeutics |